The REMEDEE trial: 5‐Year results on a novel combined sirolimus‐eluting and endothelial progenitor cells capturing stent

Objectives To evaluate the long‐term safety and efficacy of the novel combined sirolimus‐eluting endothelial progenitor cell capture Combo stent (OrbusNeich, Fort Lauderdale, FL) at 5 years in the REMEDEE (Randomized study to Evaluate the safety and effectiveness of an abluMinal sirolimus coated bio‐Engineered stEnt) trial. Background Drug–eluting stents have limited restenosis and reintervention but are complicated by late and very late...